Daniel L. Azarnoff
#142,625
Most Influential Person Now
Daniel L. Azarnoff's AcademicInfluence.com Rankings
Daniel L. Azarnoffphilosophy Degrees
Philosophy
#7503
World Rank
#10726
Historical Rank
Logic
#4552
World Rank
#5862
Historical Rank
Daniel L. Azarnoffbiology Degrees
Biology
#10174
World Rank
#13479
Historical Rank
Molecular Biology
#1451
World Rank
#1478
Historical Rank
Biochemistry
#1595
World Rank
#1727
Historical Rank
Download Badge
Philosophy Biology
Daniel L. Azarnoff's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Daniel L. Azarnoff Influential?
(Suggest an Edit or Addition)Daniel L. Azarnoff's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens (1980) (835)
- Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluent. (1977) (342)
- RESPONSE OF HEPATIC MICROBODIES TO A HYPOLIPIDEMIC AGENT, ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) (1966) (265)
- Clinical Pharmacokinetics of Methotrexate (1978) (217)
- MICROBODIES IN EXPERIMENTALLY ALTERED CELLS (1967) (210)
- Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. (1979) (200)
- Effect of environmental factors on drug metabolism: Decreased plasma half‐life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides (1969) (190)
- Plasma protein binding of tricyclic anti-depressants in man. (1969) (169)
- Pharmacokinetics of drugs in patients with the nephrotic syndrome. (1975) (151)
- Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. (1979) (146)
- HYPOLIPIDEMIC HEPATIC PEROXISOME PROLIFERATORS FORM A NOVEL CLASS OF CHEMICAL CARCINOGENS (1980) (144)
- Computer-controlled Infusion of Intravenous Dexmedetomidine Hydrochloride in Adult Human Volunteers (1993) (139)
- The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin. (1972) (136)
- Pharmacokinetics of methotrexate (1973) (133)
- Effect of route of administration and effusions on methotrexate pharmacokinetics. (1974) (126)
- Drugs as etiologic factors in the Stevens-Johnson syndrome. (1968) (126)
- Di-(2-ethylhexyl)phthalate: An industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rats and mice (1976) (125)
- Absorption of orally given digoxin preparations. (1972) (112)
- NAFENOPIN-INDUCED HEPATIC MICROBODY (PEROXISOME) PROLIFERATION AND CATALASE SYNTHESIS IN RATS AND MICE (1974) (106)
- STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE). (1965) (102)
- Clinical complications of corticosteroid therapy. A selected review. (1973) (97)
- MICROBODIES IN EXPERIMENTALLY ALTERED CELLS II. The Relationship of Microbody Proliferation to Endocrine Glands (1969) (94)
- Correlation between plasma diphenhydramine level and sedative and antihistamine effects (1978) (92)
- Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man. (1974) (87)
- Effect of cholesterol synthesis inhibition in normocholesteremic young men. (1959) (84)
- Effect of in vivo elevation of free fatty acids on protein binding of drugs. (1974) (81)
- Effect of portacaval shunt on the disposition of drugs with and without first-pass effect. (1975) (77)
- Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. (1972) (77)
- The effect of spironolactone on antipyrine metabolism in man. (1973) (75)
- Drug Protein Binding and the Nephrotic Syndrome (1976) (73)
- Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans. (1974) (65)
- Cadmium-induced Leydig cell tumors of rat testis: morphologic and cytochemical study. (1973) (64)
- Correlation between plasma diphenhydramine level and sedative and antihistamine effects. (1979) (58)
- Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB. (1973) (56)
- Absorption of digoxin from different oral preparations in normal subjects during steady state (1974) (55)
- Species Differences in Cholesterol Biosynthesis by Arterial Tissue.∗ (1958) (51)
- Plasma Levels and Excretion of Estrogens in Urine in Chronic Liver Disease (1975) (49)
- Mitochondrial cavitation and hypertrophy in rat adrenal cortex due to aminoglutethimide. (1969) (47)
- Kinetics of R and S warfarin enantiomers (1980) (45)
- Metabolic disposition of antipyrine in patients with lung cancer. (1977) (45)
- Drug interactions with warfarin. (1968) (43)
- Topical application of lindane cream (Kwell) and antipyrine metabolism. (1980) (43)
- SITE OF VANADIUM INHIBITION OF CHOLESTEROL BIOSYNTHESIS (1957) (43)
- Drug interactions: Clinical significance (1974) (42)
- A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats. (1970) (40)
- Pharmacokinetics of methotrexate (1974) (39)
- Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms. (1978) (37)
- Drugs and Drug Metabolites as Environmental Contaminants: Detection of Chlorophenoxyisobutyrate and Salicylic Acid by GC-MS (1977) (37)
- Gynecomastia induced in normal males by spironolactone (1978) (35)
- High-pressure liquid chromatographic assay of theophylline in biological fluids. (1974) (34)
- Diphenylhydantoin potency and plasma protein binding. (1975) (32)
- Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643. (1978) (32)
- Species differences in the plasma protein binding of desipramine (1968) (31)
- Incorporation of acetate-1-C14 into cholesterol by human intracranial tumors in vitro. (1958) (29)
- Association between clinical cardiac status, laboratory parameters, and digoxin usage. (1976) (29)
- The Effect of Concurrent Oral Administration of Propranolol and Disopyramide on Cardiac Function in Healthy Men (1980) (28)
- The effect of non-linear disposition kinetics on the systemic availability of disopyramide (1978) (27)
- Intersubject variation in absorption of digoxin in normal volunteers. (1975) (26)
- Micromethod for the determination of serum lipids. (1962) (25)
- Clofibrate effect on catecholamine-induced metabolic changes in humans. (1968) (25)
- Bioavailability of aminosalicylic acid and its various salts in humans. 3. Absorption from tablets. (1974) (24)
- Placental transfer of diphenylhydantoin in the goat. (1972) (24)
- Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatography. (1975) (23)
- Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouse. (1977) (23)
- A specific site of vanadium inhibition of cholesterol biosynthesis (1961) (22)
- Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline. (1977) (22)
- Quantitation of lidocaine and its deethylated metabolites in plasma and urine by gas chromatography-mass fragmentography. (1978) (21)
- The effect of DDD on barbiturate and steroid-induced hypnosis in the dog and rat. (1966) (21)
- Metabolic responses to plasma concentrations of theophylline (1979) (20)
- Quality of Extemporaneously Compounded Nitroglycerin Ointment (2007) (19)
- Inhibition of cholesterol biosynthesis in man. (1958) (19)
- Glucuronic acid conjugates of clofibrate: four isomeric structures. (1981) (18)
- Placental Transfer and Fetal Urinary Excretion of Gentamicin during Constant Rate Maternal Infusion (1975) (18)
- Clinical pharmacokinetics of disopyramide (1982) (17)
- Application of metabolic data to the evaluation of drugs. (1970) (17)
- 1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferator. (1975) (17)
- One‐year trials with halofenate, clofibrate, and placebo (1976) (17)
- Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. (1999) (16)
- Quantitation of N-demethylantipyrine in biological samples and isolation and characterization of its glucuronic acid conjugate. (1978) (15)
- Identification of methotrexate and folic acid analogs by mass spectrometry. (1978) (15)
- Dissociation of the metabolic and cardiovascular effects of the beta-adrenergic blocker practolol1 (1972) (15)
- Specificity of Enzyme Inhibition by DDD.∗ (1965) (14)
- Hyperinsulinemia secondary to chronic administration of mazindol and d‐amphetamine (1971) (14)
- Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. (1976) (13)
- Absorption and excretion of clindamycin‐2‐phosphate in children after intramuscular injection (1972) (13)
- Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation. (1977) (12)
- 662 – STRUCTURE-ACTIVITY RELATIONSHIPS OF CLOFIBRATE-LIKE COMPOUNDS ON LIPID METABOLISM (1977) (12)
- Hepatic Catalase Is Not Essential for the Hypolipidemic Action of Peroxisome Proliferators 1 (1977) (12)
- Effects of selected hypolipidemic drugs on cell ultrastructure. (1971) (12)
- Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents. (1984) (12)
- SEPARATION OF NUCLEAR SATURATED FROM UNSATURATED STEROLS. (1963) (12)
- Comparison of charcoal and attapulgite as gastrointestinal sequestrants in acute drug ingestions. (1971) (11)
- A two‐year crossover therapeutic trial with halofenate and clofibrate (1976) (11)
- Prescription writing by generic name and drug cost. (1966) (10)
- Physiologic factors in selecting human volunteers for drug studies (1972) (10)
- The effect of spironolactone on plasma levels and excretion of testosterone and oestrogens in the urine in males. (A preliminary report). (1974) (9)
- Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesis. (1977) (9)
- Diphenylhydantoin: Correlation between protein binding and albumin concentration (1975) (9)
- The clinical use of plasma drug concentrations. (1976) (8)
- Separation and identification of impurities in parenteral methotrexate dosage forms. (1978) (8)
- Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect. (1969) (8)
- Effect of noradrenaline on the action of nicotine and tyramine on isolated atria. (1961) (8)
- Inhibition of amphetamine tolerance and metabolism by propranolol. (1974) (8)
- Application of blood level data to dinical trials (1974) (7)
- The effect of hypocholesterolemic drugs on adrenal corticosteroid secretion. (1967) (7)
- Bioavailability studies on para-aminosalicylic acid and its various salts in man. I. Absorption from solution and suspension (1974) (7)
- Effect of Oxygen Tension on Drug Levels and Pharmacological Action in the Intact Animal 1 (1969) (7)
- The value of plasma-digoxin assay. (1972) (7)
- Therapeutic implications of bioavailability. (1976) (6)
- A comparison of the number of circulating blood cells in different parts of the circulatory system. (1951) (6)
- Insecticides: Effect on drug metabolism (1977) (5)
- Bioavailability studies on p-aminosalicylic acid and its various salts in man. II. Comparison of parasal and pascorbic. (1973) (5)
- The interaction between halofenate and propranolol (1976) (5)
- Effect of certain transition elements on cholesterol biosynthesis. (1961) (5)
- Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt. (1974) (5)
- Use of pharmacokinetic principles in therapy. (1973) (5)
- Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype (1980) (5)
- Kinetics of R andS warfarin enantiomers. (1980) (4)
- MICROBODIES IN EXPERIMENTALLY ALTERED CELLS (1969) (4)
- The use of digitalis. (1974) (4)
- In vitro inhibition of rat liver cholest-5en-3β-ol (cholesterol) biosynthesis by non-mercurial sulfhydryl reagents (1976) (4)
- Drug Interactions: The Potential for Adverse Effects (1972) (4)
- Omeprazole Can Prevent the Gastroduodenal Mucosal Injury Associated with Combined Use of Clopidogrel and Aspirin: 123 (2008) (4)
- Placental transfer of penicillin G during constant-rate infusion in the goat. (1973) (4)
- Assessment of the Safety and Efficacy Data for the Hypnotic Halcion(R): Results of an Analysis by an Institute of Medicine Committee (1999) (3)
- Authors’ Index Vol. 10, 1973 (1973) (3)
- A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients (1979) (3)
- Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatography. (1978) (3)
- A new method for increasing the chemotherapeutic drug concentration in the tumor tissue. (1976) (3)
- PLACENTAL TRANSFER AND FETAL URINARY EXCRETION OF GENTAMICIN DURING CONSTANT RATE MATERNAL INFUSION (1974) (3)
- Half-life of methotrexate: new evidence. (1972) (3)
- Synthesis of lidocaine‐d3 (1980) (3)
- Induction of hepatic peroxisomes, peroxisome associated enzymes and hypolipidemia in rats treated with 2 ethyl hexanoic acid and 2 ethyl hexanol (1976) (2)
- Individualization of treatment of hyperlipoproteinemic disorders. (1974) (2)
- CLINICAL PRINCIPLES OF DRUG INTERACTIONS IN THE ADULT PATIENT * (1976) (2)
- Clinical evaluation of MK-185: A new hypolipidemic drug (1972) (2)
- Hepatocarcinogenicity of wy-14,643, a hypolipidemic peroxisome proliferator. Abstr. (1978) (2)
- Panel 3: Phase III investigations (1975) (2)
- Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker (1979) (2)
- 1068 – THE EFFECT 0F PORTOCAVAL SHUNT ON THE DISPOSITION OF DRUGS WITH FIRST-PASS EFFECT (1977) (1)
- Serum digitoxin in uremic patients. (1972) (1)
- 2741 – DRUG BINDING AND HYPOALBUMINEMIC STATE (1978) (1)
- Proceedings: Alterations in the pharmacokinetics of drugs by portocaval shunt. (1975) (1)
- Clinical implications of drug metabolism--introduction. (1971) (1)
- Transdermal Absorption: A Unique Opportunity for Drug Delivery (1984) (1)
- Drug interactions. (1970) (1)
- Current status of drugs used to treat hyperlipoproteinemias. (1982) (1)
- Effect of warfarin in treatment of cancer. (1976) (1)
- The Role of the Clinical Pharmacologist in the Practice of Medicine (1979) (1)
- Letters: Nitroglycerin Patches: Further Comments (1982) (1)
- 455 – DISPOSITION OF DRUGS IN PATIENTS WITH THE NEPHROTIC SYNDROME (1977) (0)
- Drug Development: Risks and Problems (1984) (0)
- Subject Index Vol. 10, 1973 (1973) (0)
- Summary (1974) (0)
- Nitroglycerin patches: further comments. (1982) (0)
- Cardiac Function in Healthy Men (2005) (0)
- CLINICAL PHARMACOLOGY STUDY UNIT. (1965) (0)
- Propylthiouracil action in the guinea pig. (1948) (0)
- Plasma levels and excretion of estrogens in urine in chronic lever disease. (1975) (0)
- Metabolic Dispositionof Antipyrinein Patients with Lung Cancer1 (1977) (0)
- The Effects of Total Body Roentgen Irradiation On The Endocrine Glands and Other Organs of the Rat (1952) (0)
- Long-Term Effects ofClofibrate (Atromid-S) on SerumLipids inMan (1969) (0)
- Effective drug use. Drug utilization by the practicing physician. (1972) (0)
- The Profession of Medicine (1929) (0)
- Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndrome. (1976) (0)
- Thanks to Reviewers2005 (2005) (0)
- Synthesis of theophylline-8-13C (1978) (0)
- Contents, Vol. 10, 1973 (1973) (0)
- Tumors potentiating catecholamine-induced hypertension. (1971) (0)
- In defense of the Drug Research Board. (1975) (0)
- Evaluation of cholesterol synthesis in rats treated with drugs known to alter microsomal drug metabolizing enzyme activity (1974) (0)
- Evaluation of Drug Interactions, ed 1. (1974) (0)
- Pharmacology of hypolipidemic drugs. Introduction. (1971) (0)
- Thanks to Reviewers2014 (2014) (0)
- Panel Discussion on the Significance of Bioavailability (1972) (0)
- Pharmacokinetics of Disopyramid (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniel L. Azarnoff?
Daniel L. Azarnoff is affiliated with the following schools:
